Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT03059446 is registered in ClinicalTrials.gov with Tobira Therapeutics, Inc. as lead sponsor.

NCT NCT03059446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03059446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
Tobira Therapeutics, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
February 14, 2017
Completion date
January 5, 2021
Enrollment
167 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis